Puma Biotechnology

PBYINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$506.909 M

$9.82 +2.40%

Close of 22 Sept 2026

Revenue

$228.4M

#2249 by revenue

Earnings

$31.1M

#1738 by earnings

Shares outstanding

51,620,066

Latest filing cover page

P/E ratio

16.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#206Assembly BiosciencesASMB$518.2M
#207KamadaKMDA$511.9M
#208Puma BiotechnologyPBYI$506.9M
#209Contineum TherapeuticsCTNM$504.1M
#210Prothena Corp PublicPRTA$461.5M

What if Puma Biotechnology were worth as much as…

Open the what-if tool →

Gold $30.2T

$585,701.88

Per share 59,644× higher

Bitcoin $1.74T

$33,739.88

Per share 3,436× higher

Nvidia $5.52T

$106,853.16

Per share 10,881× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Puma Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.